|
|
|
Dr. Daniel H. Sterman
| NAME Daniel H. Sterman |
POSITION TITLE Assistant Professor, Department of Medicine |
| EDUCATION INSTITUTION | DEGREE | YEAR(s) | FIELD OF STUDY |
| Brown University Cornell University Medical College |
A.B. M.D. |
1985 1989 |
European History Medicine |
Professional Experience
| 1989-1992 | Internship and residency in Internal Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA |
| 1993-1995 | Pulmonary and Critical Care Clinical Fellowship, University of Pennsylvania Medical Center, Philadelphia, PA |
| 1994-1995 | Interventional Pulmonology Fellowship, Pennsylvanis Hospital/ Section of General Thoracic Surgery, University of Pennsylvania Medical Center, Philadelphia, PA |
| 1995-1996 | Research Training Fellowship. Thoracic Oncology Research Laboratory, University of Pennsylvania Medical Center, Philadelphia, PA |
| 1997-present | Faculty, Thoracic Oncology Research Laboratory, University of Pennsylvania Medical Center, Philadelphia, PA |
| 1997-present | Faculty, Pulmonary, Allergy and Critical Care Division. Department of Medicine. University of Pennsylvania Medical Center, Philadelphia, PA |
| 1997-present | Assistant Professor of Medicine; Director of Interventional Pulmonology; Clinical Director, Mesothelioma Gene Therapy Program, University of Pennsylvania Medical Center, Philadelphia, PA |
Original Papers
- Sterman DH, Treat J, Litzky LA, Amin KM, Coonrod
L, Knox L, Recio A, Mohtar-Kimber K, Wilson JM, Albelda SM, Kaiser
LR.
Adenovirus-mediated herpes simplex virus thymidine kinase gene delivery in patients with localized malignancy; Results of a phase I clinical trial in malignant mesothelioma.
Human Gene Therapy, 1998, 9(7), 1083-1092. - Sterman DH, Molnar-Kimber KL, Chang M, Elbash M,
Elshami A, Roberts JR, Treat J, Wilson JM, Kaiser LR, Albelda SM.
Humoral and cellular immune responses induced by adenoviral-based gene therapy for localized malignancy: Results of a phase I clinical trial for malignant mesothelioma.
Human Gene Therapy, 9:2121-2133, 1998. - Sterman DH, Benard F, Smith RJ, Kaiser LR, Albelda
SM, Alavi A.
Metabolic imaging of malignant pleural mesothelioma with fluorine-18-deoxyglucose positron emission tomography.
Chest, 114: 713-722, 1998. - Sterman DH, Kaiser LR, Albelda SM.
Advances in the treatment of malignant pleural mesothelioma.
Chest, 116: 504-520, 1999. - Sterman DH, Benard F, Smith RJ, Kaiser LR, Albelda
SM, Alavi A.
Prognostic Value of FDG PET Imaging in Malignant Pleural Mesothelioma.
J Nuel Med, 40: 1241-1245, 1999.